FundCanna CEO Adam Stettner Says On Rescheduling Says Optimistic But Not 'Counting On It'
Portfolio Pulse from Benzinga Newsdesk
FundCanna CEO Adam Stettner expressed optimism about the potential rescheduling of cannabis but emphasized that he is not relying on it. This cautious approach reflects the uncertainty surrounding regulatory changes in the cannabis industry.
October 08, 2024 | 6:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
The potential rescheduling of cannabis could impact MSOS, an ETF focused on U.S. cannabis companies. However, the CEO of FundCanna remains cautious, indicating uncertainty in regulatory changes.
MSOS, being an ETF focused on U.S. cannabis companies, could be affected by regulatory changes such as cannabis rescheduling. However, the cautious stance of FundCanna's CEO suggests that immediate impacts are uncertain, leading to a neutral short-term outlook.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50